A novel TGF- receptor antagonist to treat pulmonary fibrosis

Ended Project Grant Awarded Last action

Award ID
R43HL132679
Recipient
Awarding agency
Obligated
$225,881

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date
Originally
Place of performance
Olivette, MO 63132, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment -$57,686
Original award $283,567

Quick answers

Who received award R43HL132679?

R43HL132679 was awarded to Auxagen, Inc. by National Institutes of Health (Department of Health and Human Services) on June 1, 2016.

How much is award R43HL132679 worth?

$225,881 has been obligated on R43HL132679.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award